Chromosomal changes during development and progression of prostate adenocarcinomas.
about
FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome.Defining the region(s) of deletion at 6q16-q22 in human prostate cancer.The candidate oncogene CYP24A1: A potential biomarker for colorectal tumorigenesis.Allele frequency of ABO blood group antigen and the risk of esophageal cancer.CYP24A1 is an independent prognostic marker of survival in patients with lung adenocarcinoma.Prostate cancer biomarkers: a current perspective.Genomic profiling of hormone-naïve lymph node metastases in patients with prostate cancer.Relationship between ABO blood groups and carcinoma of esophagus and cardia in Chaoshan inhabitants of China.Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays.High-grade prostatic intraepithelial neoplasia of the prostate: the precursor lesion of prostate cancer.Molecular mechanisms involving prostate cancer racial disparity.Regulation of SRC kinases by microRNA-3607 located in a frequently deleted locus in prostate cancerMdm2-SNP309 polymorphism in prostate cancer: no evidence for association with increased risk or histopathological tumour characteristics.TMEFF2 is an androgen-regulated gene exhibiting antiproliferative effects in prostate cancer cells.Molecular basis for prostate cancer racial disparities.Copy number variations of circulating, cell-free DNA in urothelial carcinoma of the bladder patients treated with radical cystectomy: a prospective studyThe genomic landscape of prostate cancer.Molecular mechanisms involving prostate cancer racial disparity.Automated screening for genomic imbalances using matrix-based comparative genomic hybridization.
P2860
Q27851411-024B967B-D2DA-49DE-9705-53F630B6C11EQ30309336-4CEE1A35-B51F-4E22-9A0F-0B317697F591Q33673961-9C0662AE-1F69-4372-BD09-1C1D27BBC200Q33871373-35471A3F-295B-40BB-91BA-44777849CDCFQ34680398-6C8A81C1-1C27-4D49-8062-806965973F65Q35183650-C37EE8F0-5D3F-41CA-A6F0-DD4E31BA3041Q35613208-61E09161-587C-4095-B4F8-17D8703273B8Q36415621-D7E50156-0940-410C-B93D-2A16576D676FQ36610469-0B9DC23F-3253-4F7B-8FAB-3DFAB9EA6DEFQ37374251-E13EA3F5-3F22-4073-B504-0B6C853E9775Q37418937-109E698D-808D-4640-B76B-C500798356F2Q38996065-A384A6FB-52B1-4B74-A5B6-1B1104416D6EQ39922379-19933E10-29B2-4472-A6FC-74E0D5EA054DQ40720226-95CC5F33-2BE5-4AEA-ACC6-18CA9DDEB3C6Q41334556-A8F8FFCA-28A6-4121-9AED-597BC03FA6ACQ41346526-5435BEF5-2C02-46AD-A18A-93052058CB34Q42174920-52E84711-5900-4237-8DFF-AB27F4E9F921Q45327318-E97B8636-32DF-4195-B731-0A13A4DA6AACQ51602340-E0B09A94-BB66-40EE-A80A-348110842C7E
P2860
Chromosomal changes during development and progression of prostate adenocarcinomas.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Chromosomal changes during development and progression of prostate adenocarcinomas.
@en
Chromosomal changes during development and progression of prostate adenocarcinomas.
@nl
type
label
Chromosomal changes during development and progression of prostate adenocarcinomas.
@en
Chromosomal changes during development and progression of prostate adenocarcinomas.
@nl
prefLabel
Chromosomal changes during development and progression of prostate adenocarcinomas.
@en
Chromosomal changes during development and progression of prostate adenocarcinomas.
@nl
P2093
P2860
P356
P1476
Chromosomal changes during development and progression of prostate adenocarcinomas.
@en
P2093
Bauchinger M
Zitzelsberger H
P2860
P2888
P304
P356
10.1054/BJOC.2000.1533
P407
P50
P577
2001-01-01T00:00:00Z
P5875
P6179
1016387333